Live Breaking News & Updates on Calcutta School Of Tropical Medicine|Page 5

Stay updated with breaking news from Calcutta school of tropical medicine. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Covid: Emergency nod for foreign jabs - Telegraph India


The Centre on Tuesday waived clinical trial preconditions for emergency use authorisation of Covid-19 vaccines approved by select foreign regulatory agencies, seeking to augment India’s vaccine basket and accelerate the inoculation campaign.
The Union health ministry has accepted the recommendations of an expert panel to expedite emergency use authorisation of vaccines already approved by the US Food and Drug Administration, the European Medicines Agency, the regulatory agencies of Japan and the UK, and those listed by the World Health Organisation.
The move, advocated for weeks by sections of health experts, opens a window of opportunity for companies such as Pfizer, Moderna, and Johnson and Johnson to introduce their vaccines in India without the mandatory local clinical trials, health officials said. ....

United Kingdom , West Bengal , Vinod Paul , Giridhar Babu , Santanu Tripathi , Centre On , Drug Administration , Calcutta School Of Tropical Medicine , Indian Institute Of Public Health , World Health Organisation , European Medicines Agency , Serum Institute Of India , World Health , National Expert Group , Vaccine Administration , Niti Aayog , Serum Institute , Indian Institute , Public Health , Calcutta School , ஒன்றுபட்டது கிஂக்டம் , மேற்கு பெங்கல் , வினோத் பால் , கிரிதர் பாபு , சந்தனு திரிபாதி , மையம் ஆன் ,

Coronavirus outbreak: Beneficiaries cannot choose between AstraZeneca-Oxford and Bharat Biotech vaccine initially


India’s Covid-19 vaccination campaign starting on January 16 with the AstraZeneca-Oxford vaccine and the homegrown Bharat Biotech jab will not offer beneficiaries the option to choose between the two, the Union health ministry has signalled.
But online discussions and free-wheeling exchanges in medical circles across the country, doctors say, appear to reflect expectations among many that they would receive the AstraZeneca-Oxford vaccine called Covishield in India instead of the homegrown Covaxin.
The health ministry said on Tuesday that 11 million doses of Covishield and 5.5 million doses of Covaxin ordered by the Centre to start the campaign would be received by all states and Union Territories by January 14, but did not explain which vaccine would go where. ....

West Bengal , New Delhi , Vinod Paul , Sumit Ray , Santanu Tripathi , Rajesh Bhushan , Union Territories , Calcutta School Of Tropical Medicine , Serum Institute Of India , Bharat Biotech , Niti Aayog , Holy Family Hospital , Calcutta School , Serum Institute , மேற்கு பெங்கல் , புதியது டெல்ஹி , வினோத் பால் , சுமிட் ராய் , சந்தனு திரிபாதி , ராஜேஷ் பூஷன் , தொழிற்சங்கம் பிரதேசங்கள் , கால்குட்டா பள்ளி ஆஃப் வெப்பமண்டல மருந்து , சீரம் நிறுவனம் ஆஃப் இந்தியா , பாரத் பயோடெக் , நீதி ஆயோக் , பரிசுத்த குடும்பம் மருத்துவமனை ,

India-made Covaxin jumps direct evidence - Telegraph India


India’s drug regulatory expert panel on Saturday recommended conditional and restricted emergency use of a home-grown vaccine against the coronavirus disease without direct evidence for its protective efficacy.
Earlier on Friday, the AstraZeneca-Oxford vaccine had been recommended. The recommendations from the Subject Expert Committee (SEC) to the Central Drugs Standard Control Organisation, the apex regulatory authority for drugs and vaccines, imply India could use two vaccines for its planned campaign to initially vaccinate around 300 million people.
The Union health ministry said on Saturday the SEC had granted the permissions under multiple conditions, but some medical experts said the committee appeared to have yielded to a desire to launch an Indian-made vaccine alongside a foreign one. ....

United Kingdom , West Bengal , Santanu Tripathi , Serum Institute , Calcutta School Of Tropical Medicine , Indian Council Of Medical Research , Expert Committee , Serum Institute Of India , Central Drugs Standard Control Organisation , Subject Expert Committee , Pune Based Serum Institute , Hyderabad Based Bharat Biotech , Indian Council , Medical Research , Calcutta School , Tropical Medicine , Bharat Biotech , ஒன்றுபட்டது கிஂக்டம் , மேற்கு பெங்கல் , சந்தனு திரிபாதி , சீரம் நிறுவனம் , கால்குட்டா பள்ளி ஆஃப் வெப்பமண்டல மருந்து , இந்தியன் சபை ஆஃப் மருத்துவ ஆராய்ச்சி , நிபுணர் குழு , சீரம் நிறுவனம் ஆஃப் இந்தியா , மைய மருந்துகள் தரநிலை கட்டுப்பாடு ஆர்கநைஸேஶந் ,